1,2-dipalmitoyl-3-phosphatidylethanolamine has been researched along with Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, C; Fan, T; Han, S; Hu, L; Jiao, F; Li, W; Liu, Y; Wu, Y; Zhao, Y | 1 |
| Bally, MB; Chiu, GN; Mayer, LD | 1 |
2 other study(ies) available for 1,2-dipalmitoyl-3-phosphatidylethanolamine and Neoplasms
| Article | Year |
|---|---|
Construction of amphiphilic copolymer nanoparticles based on hyperbranched poly (amine-ester) and 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine as drug carriers for cancer therapy.
Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Delayed-Action Preparations; Doxorubicin; Female; Humans; Mice; Mice, Inbred BALB C; Nanoparticles; Neoplasms; Phosphatidylethanolamines | 2011 |
Effects of phosphatidylserine on membrane incorporation and surface protection properties of exchangeable poly(ethylene glycol)-conjugated lipids.
Topics: Animals; Cell Membrane; Drug Delivery Systems; Lipoproteins; Liposomes; Mice; Micelles; Neoplasms; Phosphatidylethanolamines; Phosphatidylserines; Polyethylene Glycols; Surface Properties; Time Factors | 2002 |